Human Bone Morphogenetic Protein-10 (BMP-10)

• Description:

  Human Bone Morphogenetic Protein-10 (BMP-10)_x000D_ Catalog number: B2018604_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 ug_x000D_ Molecular Weight or Concentration: 13.2 kDa_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20℃_x000D_ Keywords: BMP-10_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Hu Y, Yu L, Xia F, Liang F, Cheng C, Huang Y, Xiao L. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance Clin Transl Oncol. 2021 Aug;23(8):1711-1716._x000D_ 2: Ye L, Bokobza S, Li J, Moazzam M, Chen J, Mansel RE, Jiang WG. Bone morphogenetic protein-10 (BMP-10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer Cancer Sci. 2010 Oct;101(10):2137-44._x000D_ 3: Ye L, Kynaston H, Jiang WG. Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad independent pathway J Urol. 2009 Jun;181(6):2749-59._x000D_ 4: Yan Y, Gong P, Jin W, Xu J, Wu X, Xu T, Hang Q, Fu H, Kei K, Gao Y. The cell-specific upregulation of bone morphogenetic protein-10 (BMP-10) in a model of rat cortical brain injury J Mol Histol. 2012 Oct;43(5):543-52._x000D_ 5: Jin Y, Zheng W, Li L, Huang G, Liu Y, Jiang H, Zhang Y, Tang C. Loss of BMP-10 is correlated with poor survival in ovarian cancer Pathol Res Pract. 2019 Jan;215(1):121-126._x000D_ 6: Zhang Y, Phillips FM, Thonar EJ, Oegema T, An HS, Roman-Blas JA, He TC, Anderson DG. Cell therapy using articular chondrocytes overexpressing BMP-7 or BMP-10 in a rabbit disc organ culture model Spine (Phila Pa 1976). 2008 Apr 15;33(8):831-8._x000D_ 7: Hennings E, Aeschbacher S, Coslovsky M, Paladini RE, Meyre PB, Voellmin G, Blum L, Kastner P, Ziegler A, Conen D, Zuern CS, Krisai P, Badertscher P, Sticherling C, Osswald S, Knecht S, Kühne M. Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation Europace. 2023 Jun 2;25(6):euad149._x000D_ 8: Gupta S, Gill D, Pal SK, Agarwal N. Activin receptor inhibitors--dalantercept Curr Oncol Rep. 2015 Apr;17(4):14._x000D_ 9: Owen NE, Nyimanu D, Kuc RE, Upton PD, Morrell NW, Alexander GJ, Maguire JJ, Davenport AP. Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10 Peptides. 2021 Feb;136:170440._x000D_ 10: Hennings E, Blum S, Aeschbacher S, Coslovsky M, Knecht S, Eken C, Lischer M, Paladini RE, Krisai P, Reichlin T, Rodondi N, Beer JH, Ammann P, Conte G, De Perna ML, Kobza R, Blum MR, Bossard M, Kastner P, Ziegler A, Müller C, Bonati LH, Pfister O, Zuern CS, Conen D, Kühne M, Osswald S; Swiss‐AF Investigators. Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation J Am Heart Assoc. 2023 Mar 21;12(6):e028255. _x000D_ _x000D_ Products Related to Human Bone Morphogenetic Protein-10 (BMP-10) can be found at Proteins

• Short Description:

  Catalog Number: B2018604 (1 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5